Tirzepatide is a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for two distinct indications: type 2 diabetes mellitus (marketed as Mounjaro) and chronic weight management (marketed as Zepbound)
Indeed, GCG antagonists, developed as potential glucose-lowering therapies, were associated with an increase in hepatic steatosis [38], suggesting that GCG agonists may reduce hepatic steatosis [39]
In experimental models, they preserved dopaminergic neurons and improved motor performance via mitochondrial and endoplasmic reticulum stress pathways (Sedky and Magdy, 2021)
Cilona notes that everyone deals with stress differently, so its a good idea to ask your partner what you can do to help, and to do it often
FDA warned consumers to avoid homeopathic HCG weight-loss diet products because they don't work, often make unsupported claims, and are illegal for sale
Are BPC-157 and TB-500 approved medicines